 |
EnWave Corporation is a life sciences R&D
company developing commercial applications for our Radiant
Energy Vacuum (REV) technology. Developed in conjunction with the University of British
Columbia, REV is used to dehydrate liquid pharmaceuticals and food products. Our goal is
to replace the industry standard of freeze-drying, which is an expensive and labour intensive process.
 |
bioREV for liquid
pharmaceuticals
Designed for the dehydration of liquid pharmaceuticals containing sensitive
biological material such as vaccines and antibodies.
bioREV is being tested for feasibility in producing room temperature
stable vaccines and antibodies that can be shipped worldwide without refrigeration,
and stockpiled to protect against pandemic diseases and bioterrorism. |
 |
nutraREV for
food
Designed for the dehydration of fruits, vegetables, nutraceuticals and food cultures such as probiotics and enzymes, to
provide higher nutritional content and improved appearance and flavour over conventional
methods. A commercial-scale nutraREV machine is currently
being tested by a food industry partner to determine the commercial viability
of this technology. |
|
|
|
|
|
 |
May 7, 08 • EnWave Changes Terms of Private Placement
READ MORE |
| |
|
May 6, 08 • EnWave Announces Private Placement
READ MORE |
| |
|
May 1, 08 • EnWave Receives Positive Shelf-Life Results from
Vaccine Dehydration Testing
READ MORE |
|
|
|
 |
Corporate Fact
Sheet (PDF) |
Corporate Presentation (PDF) |
|
|
|
|
|
|